T-cell bispecific antibodies to bypass MHC class I loss in breast cancer

Ann Oncol. 2019 Jun 1;30(6):877-879. doi: 10.1093/annonc/mdz115.

Authors

A Marra¹, G Curigliano²

Affiliations

¹ Department of Hematology and Oncology, European Institute of Oncology, IRCCS, University of Milano, Milano, Italy.
² Department of Hematology and Oncology, European Institute of Oncology, IRCCS, University of Milano, Milano, Italy. Electronic address: giuseppe.curigliano@ieo.it.

PMID: 30938431
DOI: 10.1093/annonc/mdz115

No abstract available

Publication types

Editorial
Comment

MeSH terms

Antibodies, Bispecific*
Breast Neoplasms*
Humans
Lymphocyte Activation
T-Lymphocytes / immunology

Substances

Antibodies, Bispecific